Innovative Approaches to the Liver Tumors: Molecular, Imaging, Surgical and Artificial Intelligence Applications in Clinical Practice
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 4087
Special Issue Editors
2. Division of Hepatobiliary Surgery, Department of Surgery, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy
3. Surgical Data Science Team, Institut de Recherche sur les Cancers de l’Appareil Digestif (IRCAD), 67000 Strasbourg, France
Interests: artificial intelligence in surgery; data science in surgery; hepatocellular carcinoma; colorectal liver metastases; advanced ultrasound guided liver surgery; circulating tumor cells in liver tumors; hyperspectral imaging; parenchymal sparing surgery
Interests: colorectal liver metastases; hepatocellular carcinoma; cholangiocarcinoma; minimally invasive liver surgery; robotic liver resection; parenchymal sparing liver resection; hepatic hypertrophy technique
Special Issue Information
Dear Colleagues,
Liver tumors can have a significant impact on overall health. The advancement of technology and medicine has enabled the development of innovative approaches to the treatment of liver tumors: from molecular biology to tailor the treatment allocation, through novel bio-imaging (such hyperspectral camera, functional MRI, perfusions etc) to estimate the remnant liver function or to drive precisely the surgical resection, to the novel applications of artificial intelligence. This special issue aims to bring together experts from a variety of fields to discuss and share their latest research findings on the innovative approaches to liver tumors and their relative surgical approach. By providing a comprehensive overview of the latest developments in this field, this special issue will provide valuable insights for researchers, clinicians, and other healthcare professionals interested in this topic.
We look forward to receiving your contributions!
Dr. Simone Famularo
Dr. Francesco Ardito
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver tumors
- molecular biology
- imaging
- surgery
- artificial intelligence
- mini-invasive liver surgery
- innovative approaches
- hyperspectral imaging
- surgical oncology